Investors

This section of the website provides financial reports, investor presentations, information on key corporate transactions and much more.

We strive to be transparent, relevant and accurate in presenting our financial information, in order to inform our stakeholders of the company’s operations and financial position.

If you have any questions, please don’t hesitate to contact us at investors@c-rad.com
Svensk version här

Sign up to our newsletter to keep up to date with investor news

Five reasons to invest in C-RAD

  • Contributing to improved cancer care and ultimately saving human life
  • Several factors point towards surface tracking becoming standard of care – which will unleash a vast market potential for C-RAD with exponential revenue growth
  • C-RAD has a proven and recognized product
  • C-RAD has comprehensive market access with a direct sales force, distributors, and direct cooperation with OEM-vendors
  • C-RAD has a stable financial platform – profitable growth, debt free and +100 MSEK in cash
Learn more

Press releases

2024-05-04 13:00 C-RAD and RaySearch sign collaboration agreement News Corporate Information Other Corporate Information English IR
2024-05-04 13:00 C-RAD och RaySearch tecknar samarbetsavtal News Corporate Information Other Corporate Information Swedish IR
2024-05-03 11:30 C-RAD Web Presentation Interim Report Q1 2024 News Corporate Information Presentation English IR
2024-04-24 13:00 The Nomination Committee’s revised proposal before the Annual General Meeting 2024 News Corporate Information Nomination Committee English Regulatory Listing Regulation IR
2024-04-24 13:00 Valberedningens reviderade förslag inför årsstämman 2024 News Corporate Information Nomination Committee Swedish Regulatory Listing Regulation IR
2024-04-23 16:35 C-RAD publicerar årsredovisning för 2023 News Swedish Regulatory VPML Report Annual IR

Shares & stock

Please feel free to contact us regarding investments or other financial questions

If you have any questions, please don’t hesitate to contact us